Expertise in
35
conditions

Dr. Eric C. Leuthardt

Neurosurgery
Washington University
660 S Euclid Ave, 
Saint Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
35
conditions
Washington University
660 S Euclid Ave, 
Saint Louis, MO 

Overview

Eric Leuthardt is a Neurosurgery provider practicing medicine in Saint Louis, Missouri.

Dr. Leuthardt is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery.

He is actively involved in clinical research, co-authoring 214 peer reviewed articles and participating in 9 clinical trials. Dr. Leuthardt is currently accepting new patients.

Specialties

Neurosurgery

Licenses

Neurological Surgery in MO

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Memorial Hospital
Missouri Baptist Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Washington University
660 S Euclid Ave, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Enrollment Status: Recruiting
Publish Date: May 14, 2026
Intervention Type: Genetic, Device, Procedure
Study Phase: Not Applicable
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized in Patients With Newly Diagnosed, Unmethylated Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2026
Intervention Type: Device, Biological, Drug
Study Drugs: Personalized neoantigen DNA vaccine, Plasmid encoded IL-12
Study Phase: Phase 1
A Phase I/II Study Testing the Safety, Toxicities, and Efficacy of MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
A Phase I/II Study Testing the Safety, Toxicities, and Efficacy of MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Biological, Device
Study Drug: Pembrolizumab
Study Phase: Phase 1/Phase 2
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
A Phase I/II Dose-escalation and Dose-expansion Study of Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Completed
Publish Date: April 10, 2025
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Disulfiram, Copper Gluconate, Temozolomide
Study Phase: Phase 1/Phase 2
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Enrollment Status: Terminated
Publish Date: November 01, 2024
Intervention Type: Drug, Device
Study Drugs: Doxorubicin, Etoposide
Study Phase: Phase 2
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Immunogenicity of a Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Enrollment Status: Terminated
Publish Date: October 27, 2021
Intervention Type: Procedure, Biological
Study Phase: Phase 1
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
A Pilot Study of Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Doxorubicin in the Treatment of Recurrent Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: August 27, 2021
Intervention Type: Device, Drug, Other
Study Phase: Phase 1
A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
A Pilot Study to Assess the Safety, Feasibility, and Preliminary Efficacy of a Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Terminated
Publish Date: November 17, 2017
Intervention Type: Drug, Biological
Study Phase: Phase 1
View 8 Less Clinical Trials

214 Total Publications

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 17, 2026
Similar Doctors
Expertise in
19
conditions
Expertise in
19
conditions
Referral may be required

St. Louis Children's Hospital

1 Childrens Pl, 
Saint Louis, MO 
 (0.2 miles away)
314-454-2810
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Limbrick is a Neurosurgery provider practicing medicine in Saint Louis, Missouri. Dr. Limbrick is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Chiari Malformation Type 2, Syringomyelia, Hydrocephalus, Posterior Fossa Decompression, and Nerve Decompression. Dr. Limbrick is currently accepting new patients.

Expertise in
72
conditions
Expertise in
72
conditions
Referral may be required

Office

4921 Parkview Pl Ste 6C, 
Saint Louis, MO 
 (0.1 miles away)
314-362-3577
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Chicoine is a Neurosurgery provider practicing medicine in Saint Louis, Missouri. Dr. Chicoine is highly rated in 72 conditions, according to our data. His clinical expertise encompasses Meningioma, Pituitary Tumor, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Nerve Decompression. Dr. Chicoine is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required

Office

1 Childrens Pl Ste 4S20, 
Saint Louis, MO 
 (0.7 miles away)
314-454-2810
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jennifer Strahle is a Neurosurgery provider practicing medicine in Saint Louis, Missouri. Dr. Strahle is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Chiari Malformation Type 2, Syringomyelia, Chiari Malformation, Posterior Fossa Decompression, and Endoscopy. Dr. Strahle is currently accepting new patients.

Frequently Asked Questions about Dr. Eric C. Leuthardt

How do I make an appointment with Dr. Eric C. Leuthardt?

You can book an appointment with Dr. Eric C. Leuthardt by calling their office at 314-362-3577. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eric C. Leuthardt a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eric C. Leuthardt is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eric C. Leuthardt specialize in?

While Dr. Eric C. Leuthardt is a Neurosurgery, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Eric C. Leuthardt participate in research or clinical trials?

Yes. Dr. Eric C. Leuthardt has published 214 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Eric C. Leuthardt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Eric C. Leuthardt accept my insurance?

Dr. Eric C. Leuthardt accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-362-3577 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Leuthardt's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 17 Advanced Conditions
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile